Merit Financial Group »

ACADIA Pharmaceuticals shares owned by Merit Financial Group

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Merit Financial Group from 13F filings

Historical chart of Merit Financial Group investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by Merit Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by Merit Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 39k 26.71

More positions owned by Merit Financial Group

Vanguard Index Fds Growth Etf (VUG)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Us Gwt (IUSG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust State Street Spd (SPTI)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Merit Financial Group

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
BlackRock
Vanguard Group
State Street Corporation
Rtw Investments
Point72 Asset Management
Geode Capital Management
Dimensional Fund Advisors
Adage Capital Partners GP
Palo Alto Investors
First Trust Advisors
Braidwell
Goldman Sachs Group
Fred Alger Management
D. E. Shaw & Co

View all funds holding ACADIA Pharmaceuticals